In Reply: Mega-trials for blockbusters are readily feasible. There would be no cost for the government or health care system. Drug production cost to industry (as opposed to sales cost) is negligible. The proposed mandate could easily stipulate that blockbuster manufacturers donate drugs and placebos for such trials. Total cost to the industry would be approximately 1% of their cumulative sales for the product.
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Intraclass medication similarities are often quoted, but evidence to support the concept is thin and not tested with large-scale evidence. 2 Same-class drugs are not necessarily interchangeable; the proposed mega-trials can inform which are and which are not.
End points by definition will include mortality and major, important clinical outcomes for which there is no risk of clinical insignificance. Mortality is always an important outcome, even for drugs that treat arthritis, erectile dysfunction, or pain. 3 Major clinical end points should exist for each drug and its uses. If not, why should we spend billions on a drug that cannot affect any major clinical end points?
The initiatives mentioned by Drs Landy and Hecht are all worthwhile efforts. However, they are of relatively narrow scope compared with a stable multibillion dollar agenda devoted to high-quality mega-trials. Instead of isolated efforts trying to impede industry cheating or sprinkling some money on dubious 1-time initiatives and comparative effectiveness chaos, the proposed agenda can improve patient outcomes, reward innovative companies that produce the best products, and sustain a high-quality RCT agenda.
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RESEARCH LETTER

Firearm Injuries of Children and Adolescents in 2 Colorado Trauma Centers: 2000-2008
To the Editor: Given recent firearm-related fatalities combined with declining gun research funding, 1 it is important to monitor firearm injuries in youths. Injury death rates are available but provide an incomplete picture of these potentially preventable injuries. 2 Investigations on temporal trends of both fatal and nonfatal firearm injuries remain scarce. [3] [4] [5] Our objective was to investigate temporal trends of both fatal and nonfatal firearm injuries in children and adolescents presenting to 2 Colorado urban trauma centers.
Methods. We queried the trauma registries of 2 level 1 trauma centers in Denver and Aurora, Colorado, from 2000 to 2008 for all injuries occurring in children and adoles-cents aged 4 to 17 years (hereafter referred to as youth). Trauma registries are mandated in Colorado and include all level 1 trauma center patients with 1 or more of the following criteria: in-hospital death (deaths at scene are not included), admission to hospital unit, highest level trauma team activation, longer than 12 hours of observation, or Injury Severity Score 6 (ISS; range, 0-75) greater than 9. Variables reported had complete data, except for race/ ethnicity (2.8% missing) and ISS (1% missing). Missing values were not associated with other variables, suggesting random missingness. Injury was classified as self-inflicted if there was unequivocal information that the patient injured himself or herself purposefully or by accident. Intention is not consistently reported and was not assessed.
The Colorado Multiple Institutional Review Board considered the study exempt and did not require informed consent.
We compared firearm injuries with other injuries regarding patient characteristics (age, sex, race/ethnicity [white non-Latino vs others], injury self-infliction, ISS, mortality, and intensive care requirement). We analyzed temporal trends regarding patient and injury characteristics as well as outcomes among fatal and nonfatal firearm injuries.
Wilcoxon or Spearman rank correlation tests were used for continuous variables and 2 or Fisher exact tests were used for proportions. The categorical outcomes were adjusted for age, sex, white non-Latino race/ethnicity, ISS, and temporal trends through logistic regression; and goodness of fit was assessed with C statistics. Variables are reported by triennials for simplicity but annual data were used for analysis.
Statistical analyses were performed using SAS version 9.3 (SAS Institute Inc). Tests were 2-sided, with significance established at a P value of .05.
Results. Overall, 6920 youths were injured. Firearms caused the injury in 129 of these youths (1.9%) ( Discussion. Firearms were an important mechanism of injury in the youth in this study. Compared with other serious injuries, firearm injuries were more severe, more of- ten required intensive care, and claimed more lives, justifying focusing on pediatric firearm injuries as a prevention priority. Study limitations include trauma registry deficiencies (such as inconsistent capturing of intentionality and exclusion of deaths at scene, which is a significant fraction of firearmrelated deaths); and data restricted to 2 trauma centers, which may not generalize to other regions. In addition, data were available only until 2008; however, there has been no substantial decline in published firearm death rates in Colorado since 2008 (2.2 per 100 000 persons aged 4-17 years in 2000, 1.9 in 2009, and 2.8 in 2011).
More recent data from other areas with detail on the circumstances of the firearm injury are needed.
